Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 11.248\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) O=C(CN1CCN(c2ccccn2)CC1)Nc1cccc(S(=O)(=O)N2CCCC2)c1
(b) COc1ccccc1NC(=O)Cn1nnc2sc3c(c2c1=O)CC(C)(C)OC3
(c) COc1ccc(CCNC(=O)CCNS(=O)(=O)c2cccc3nsnc23)cc1OC
Answer: c. COc1ccc(CCNC(=O)CCNS(=O)(=O)c2cccc3nsnc23)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCNC(=O)CCNS(=O)(=O)c2cccc3nsnc23)cc1OC
COc1ccc(CCNC(=O)CCNS(=O)(=O)c2cccc3nsnc23)cc1OC
3-(2,1,3-benzothiadiazol-4-ylsulfonylamino)-N-[2-(4,5-dimethoxyphenyl)ethyl]propanamide